Cargando…

Mapping the Patient-Reported Outcomes Measurement Information System (PROMIS-29) to EQ-5D-5L

BACKGROUND AND OBJECTIVE: The Patient-Reported Outcomes Measurement Information System (PROMIS-29) is gaining popularity as healthcare system funders increasingly seek value-based care. However, it is limited in its ability to estimate utilities and thus inform economic evaluations. This study devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Aghdaee, Mona, Gu, Yuanyuan, Sinha, Kompal, Parkinson, Bonny, Sharma, Rajan, Cutler, Henry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883346/
https://www.ncbi.nlm.nih.gov/pubmed/36336773
http://dx.doi.org/10.1007/s40273-022-01157-3
_version_ 1784879489387331584
author Aghdaee, Mona
Gu, Yuanyuan
Sinha, Kompal
Parkinson, Bonny
Sharma, Rajan
Cutler, Henry
author_facet Aghdaee, Mona
Gu, Yuanyuan
Sinha, Kompal
Parkinson, Bonny
Sharma, Rajan
Cutler, Henry
author_sort Aghdaee, Mona
collection PubMed
description BACKGROUND AND OBJECTIVE: The Patient-Reported Outcomes Measurement Information System (PROMIS-29) is gaining popularity as healthcare system funders increasingly seek value-based care. However, it is limited in its ability to estimate utilities and thus inform economic evaluations. This study develops the first mapping algorithm for estimating EuroQol 5-Dimension 5-Level (EQ-5D-5L) utilities from PROMIS-29 responses using a large dataset and through extensive comparisons between econometric models. METHODS: An online survey was conducted to collect responses to PROMIS-29 and EQ-5D-5L from the general Australian population (N = 3013). Direct and indirect mapping methods were explored, including linear regression, Tobit, generalised linear model, censored regression model, beta regression (Betamix), the adjusted limited dependent variable mixture model (ALDVMM) and generalised ordered logit. The most robust model was selected by assessing the performance based on average ten-fold cross-validation geometric mean absolute error and geometric mean squared error, the predicted mean, maximum and minimum utilities, as well as the fitting across the entire distribution. RESULTS: The direct approach using ALDVMM was considered the preferred model based on lowest geometric mean absolute error and geometric mean squared error in cross-validation (0.0882, 0.0299) and its superiority in predicting the actual observed mean, full health states and lower utility extremes. The robustness and precision in prediction across the entire distribution of utilities with ALDVMM suggest it is an accurate and valid mapping algorithm. Moreover, the suggested mapping algorithm outperformed previously published algorithms using Australian data, indicating the validity of this model for economic evaluations. CONCLUSIONS: This study developed a robust algorithm to estimate EQ-5D-5L utilities from PROMIS-29. Consistent with the recent literature, the ALDVMM outperformed all other econometric models considered in this study, suggesting that the mixture models have relatively better performance and are an ideal candidate model for mapping. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40273-022-01157-3.
format Online
Article
Text
id pubmed-9883346
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-98833462023-01-29 Mapping the Patient-Reported Outcomes Measurement Information System (PROMIS-29) to EQ-5D-5L Aghdaee, Mona Gu, Yuanyuan Sinha, Kompal Parkinson, Bonny Sharma, Rajan Cutler, Henry Pharmacoeconomics Original Research Article BACKGROUND AND OBJECTIVE: The Patient-Reported Outcomes Measurement Information System (PROMIS-29) is gaining popularity as healthcare system funders increasingly seek value-based care. However, it is limited in its ability to estimate utilities and thus inform economic evaluations. This study develops the first mapping algorithm for estimating EuroQol 5-Dimension 5-Level (EQ-5D-5L) utilities from PROMIS-29 responses using a large dataset and through extensive comparisons between econometric models. METHODS: An online survey was conducted to collect responses to PROMIS-29 and EQ-5D-5L from the general Australian population (N = 3013). Direct and indirect mapping methods were explored, including linear regression, Tobit, generalised linear model, censored regression model, beta regression (Betamix), the adjusted limited dependent variable mixture model (ALDVMM) and generalised ordered logit. The most robust model was selected by assessing the performance based on average ten-fold cross-validation geometric mean absolute error and geometric mean squared error, the predicted mean, maximum and minimum utilities, as well as the fitting across the entire distribution. RESULTS: The direct approach using ALDVMM was considered the preferred model based on lowest geometric mean absolute error and geometric mean squared error in cross-validation (0.0882, 0.0299) and its superiority in predicting the actual observed mean, full health states and lower utility extremes. The robustness and precision in prediction across the entire distribution of utilities with ALDVMM suggest it is an accurate and valid mapping algorithm. Moreover, the suggested mapping algorithm outperformed previously published algorithms using Australian data, indicating the validity of this model for economic evaluations. CONCLUSIONS: This study developed a robust algorithm to estimate EQ-5D-5L utilities from PROMIS-29. Consistent with the recent literature, the ALDVMM outperformed all other econometric models considered in this study, suggesting that the mixture models have relatively better performance and are an ideal candidate model for mapping. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40273-022-01157-3. Springer International Publishing 2022-11-07 2023 /pmc/articles/PMC9883346/ /pubmed/36336773 http://dx.doi.org/10.1007/s40273-022-01157-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research Article
Aghdaee, Mona
Gu, Yuanyuan
Sinha, Kompal
Parkinson, Bonny
Sharma, Rajan
Cutler, Henry
Mapping the Patient-Reported Outcomes Measurement Information System (PROMIS-29) to EQ-5D-5L
title Mapping the Patient-Reported Outcomes Measurement Information System (PROMIS-29) to EQ-5D-5L
title_full Mapping the Patient-Reported Outcomes Measurement Information System (PROMIS-29) to EQ-5D-5L
title_fullStr Mapping the Patient-Reported Outcomes Measurement Information System (PROMIS-29) to EQ-5D-5L
title_full_unstemmed Mapping the Patient-Reported Outcomes Measurement Information System (PROMIS-29) to EQ-5D-5L
title_short Mapping the Patient-Reported Outcomes Measurement Information System (PROMIS-29) to EQ-5D-5L
title_sort mapping the patient-reported outcomes measurement information system (promis-29) to eq-5d-5l
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883346/
https://www.ncbi.nlm.nih.gov/pubmed/36336773
http://dx.doi.org/10.1007/s40273-022-01157-3
work_keys_str_mv AT aghdaeemona mappingthepatientreportedoutcomesmeasurementinformationsystempromis29toeq5d5l
AT guyuanyuan mappingthepatientreportedoutcomesmeasurementinformationsystempromis29toeq5d5l
AT sinhakompal mappingthepatientreportedoutcomesmeasurementinformationsystempromis29toeq5d5l
AT parkinsonbonny mappingthepatientreportedoutcomesmeasurementinformationsystempromis29toeq5d5l
AT sharmarajan mappingthepatientreportedoutcomesmeasurementinformationsystempromis29toeq5d5l
AT cutlerhenry mappingthepatientreportedoutcomesmeasurementinformationsystempromis29toeq5d5l